Literature DB >> 19184373

Influence of ethanol on physical state of freeze-dried mannitol.

Akira Takada1, Steven L Nail, Masakatsu Yonese.   

Abstract

PURPOSE: The purpose of this study is to characterize freeze-dried mannitol prepared from an ethanol-containing solution as a function of the ethanol ratio, mannitol concentration, and annealing in the freeze-drying cycle.
METHODS: The characteristics of the freeze-dried mannitol were evaluated by X-ray diffractometry (XRD) and differential scanning calorimetry (DSC). The reconstitution time was measured for the freeze-dried solids as well as the residual moisture and ethanol by Karl-Fischer titration and gas chromatography, respectively.
RESULTS: The XRD pattern of 5% (w/v) mannitol freeze-dried from aqueous solution with no annealing cycle showed all the five characteristic peaks at 13.6 degrees and 17.2 degrees 2theta for the alpha polymorph, at 14.6 degrees and 23.4 degrees 2theta for the beta polymorph and at 9.7 degrees 2theta for the delta polymorph. The addition of ethanol to the initial solutions resulted in only a peak at 9.7 degrees 2theta, indicating the presence of only the delta polymorph, regardless of the ethanol ratio in the initial solutions used [10, 20, 30, and 40% (v/v)]. However, annealing during freeze-drying influenced the XRD pattern; in particular, for the solid prepared from the 10% ethanol solution. Annealing of the 10% ethanol solution promoted the formation of the alpha polymorph and produced a different peak that might be attributable to another polymorph. In DSC thermograms, an endotherm and a subsequent exotherm were found in the temperature range of 150 degrees C to 160 degrees C, which corresponded to the transition of the delta form to alpha or beta forms. The magnitude of this transition was smaller as the ethanol ratio increased for the solids from ethanol-containing solutions with an annealing cycle. In other words, annealing of the ethanol-containing solutions promoted delta polymorph formation in the lyophiles. In addition, the mannitol concentration affected the polymorphism in freeze-dried solids prepared from aqueous and 10% ethanol solutions. Addition of ethanol in the initial solution, in particular, at a lower ethanol level (10% v/v), and a higher concentration of mannitol could also promote the generation of lumps in freeze-dried solids during reconstitution, and result in longer reconstitution time. The residual moisture levels were less than 0.5%, and residual ethanol levels were less than 0.1%, irrespective of the formulation used.
CONCLUSIONS: The physical state and reconstitution time of the freeze-dried mannitol appears to be a complex function of the ethanol and mannitol concentrations in the initial solution before freeze-drying and of annealing during the freeze-drying process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184373     DOI: 10.1007/s11095-009-9829-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Existence of a mannitol hydrate during freeze-drying and practical implications.

Authors:  L Yu; N Milton; E G Groleau; D S Mishra; R E Vansickle
Journal:  J Pharm Sci       Date:  1999-02       Impact factor: 3.534

2.  The physical state of nafcillin sodium in frozen aqueous solutions and freeze-dried powders.

Authors:  N Milton; S L Nail
Journal:  Pharm Dev Technol       Date:  1996-10       Impact factor: 3.133

3.  Polymorphic changes of mannitol during freeze-drying: effect of surface-active agents.

Authors:  R Haikala; R Eerola; V P Tanninen; J Yliruusi
Journal:  PDA J Pharm Sci Technol       Date:  1997 Mar-Apr

4.  The effect of bulking agent on the solid-state stability of freeze-dried methylprednisolone sodium succinate.

Authors:  B D Herman; B D Sinclair; N Milton; S L Nail
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

5.  Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents.

Authors:  S Wittaya-Areekul; S L Nail
Journal:  J Pharm Sci       Date:  1998-04       Impact factor: 3.534

6.  The impact of protein concentration on mannitol and sodium chloride crystallinity and polymorphism upon lyophilization.

Authors:  Daniel Dixon; Serguei Tchessalov; Anthony Barry; Nicholas Warne
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

7.  Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry.

Authors:  R K Cavatur; R Suryanarayanan
Journal:  Pharm Dev Technol       Date:  1998-11       Impact factor: 3.133

8.  Crystallization of D-mannitol in binary mixtures with NaCl: phase diagram and polymorphism.

Authors:  Chitra Telang; Raj Suryanarayanan; Lian Yu
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

9.  Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-01       Impact factor: 1.645

10.  Subambient behavior of mannitol in ethanol-water co-solvent system.

Authors:  Akira Takada; Steven L Nail; Masakatsu Yonese
Journal:  Pharm Res       Date:  2008-11-12       Impact factor: 4.200

View more
  3 in total

1.  Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.

Authors:  Xiaojian Li; Frederick G Vogt; Don Hayes; Heidi M Mansour
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-02-06       Impact factor: 2.849

2.  Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

3.  Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model.

Authors:  Sabri Sudirman; Ching-Shu Lai; Yi-Ling Yan; Hung-I Yeh; Zwe-Ling Kong
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.